A notable uptick in bioterrorism attack is slated to boost biodefense market size following the influence of biological agents, including Ebola, anthrax, fever viruses, smallpox, and plague.
A notable uptick in bioterrorism attack is slated to boost biodefense market size following the influence of biological agents, including Ebola, anthrax, fever viruses, smallpox, and plague. Biodefense cashes in on medical measures and uses vaccinations and medicines against bioterrorist attacks.
A biological revolution and advances in biotechnology project a promising growth that will potentially bring a paradigm shift in modern medicine. Robust growth in next-generation sequencing (NGS) technologies has furthered the research in biodefense to identify and characterize pathogens.
Rise in research development activities has underpinned the production and supply of vaccines, drugs, and diagnostic test for disease agents. According to the latest research report collated by Global Market Insights, Inc., biodefense market size is projected to surpass US$17 billion by 2024.
Some of the trends which are likely to help stakeholders gain a competitive edge in the industry are elucidated below:
Investment in anthrax vaccines to be more noticeable
With zoonotic diseases such as anthrax being one of the major public health concerns in emerging economies, infusion of funds in anthrax vaccines has become more pronounced in the past several years. Biological agents such as anthrax are a viable weapon for bioterrorism as they are easily found in nature and can be released quietly.
Infusion of funds towards the development of anthrax vaccines will muster up confidence of leading players vying to expand their penetration. With the rise in the number of people being exposed to the bacteria which causes anthrax, anthrax vaccination will gain grounds in the ensuing period.
Research and development activities to boost the supply chain process of inhalation anthrax animal models and efficacy analysis of vaccines in rabbits will augur well for leading companies eyeing to boost biodefense industry value. It is worth noting that inhalation anthrax is one of the most serious form which can kill quickly if not treated immediately.
To access sample pages of this report titled, “Biodefense Market Size By Product (Vaccines {Anthrax, Smallpox, Botulism}, Biothreat Detection Devices {Samplers, Detectors/Triggering Devices, Identifiers, Assays And Reagents}), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast 2024” in detail along with the table of contents, please click on the link below:
https://www.gminsights.com/request-sample/detail/714
Biothreat detection devices
Current trends suggest increased traction towards biothreat detection devices given the surge in technological advances to provide seamless service to the end-users. Early detection of bioagents will remain instrumental in protection, prevention, prophylaxis, mitigation, and post-exposure treatment.
Use of immunological assays such as immunochromatographic test (ICT) such as real-time RT-PCR, polymerase chain reaction (PCR), and next-generation sequencing (NGS) technology has accentuated growth in biodefense industry. Accordingly, traction for biothreat detection devices, including assays and reagents and detectors will boost confidence of the stakeholders.
Infusion of funds in North America to boost revenue stream
Legacy players are slated to infuse funds in North America considering pouring of funds in research and development of medical countermeasures against infectious diseases and radiation exposure. For instance, NBACC facility provides intelligence assessments, quick response, preparedness planning, bio-forensic analysis, and emerging threat characterization.
Europe is also likely to be perceived as a happy investment hub for vaccines and biothreat detection devices. More importantly, study predicts U.K. biodefense market share to gain a substantial uptick in the next five years. Favorable government initiatives and technological advancements will further the industry outlook in the region.
About Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Website: https://www.gminsights.com